Is minocycline useful for therapy of acute viral encephalitis?

Antiviral Research

Volumn 95, Issue 3, 2012, Pages 242-244

  Jackson, Alan C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Encephalomyelitis; Minocycline; Rabies; Rabies virus; Viral encephalitis

Indexed keywords

MINOCYCLINE;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; BRAIN INJURY; COGNITIVE DEFECT; DISEASE COURSE; DISEASE EXACERBATION; DOPAMINERGIC NERVE CELL; DRUG EFFECT; HAPLORHINI; HIV ASSOCIATED DEMENTIA; HUMAN; HUNTINGTON CHOREA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; MORBIDITY; MORTALITY; NEUROPROTECTION; NONHUMAN; NOTE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RABIES; REOVIRUS INFECTION; SINDBIS VIRUS; VIRUS ENCEPHALITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG TOXICITY; ENCEPHALITIS, VIRAL; ENCEPHALOMYELITIS; MICE; MINOCYCLINE; TREATMENT OUTCOME;

ANIMALIA; MUS; ORTHOREOVIRUS; RABIES VIRUS; SINDBIS VIRUS;

EID: 84865291515     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.06.005     Document Type: Note

References (25)

1. Casha S., Zygun D., McGowan M.D., Bains I., Yong V.W., John H.R. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain 2012, 135:1224-1236.
2. Chen X., Ma X., Jiang Y., Pi R., Liu Y., Ma L. The prospects of minocycline in multiple sclerosis. J. Neuroimmunol. 2011, 235:1-8.
3. Darman J., Backovic S., Dike S., Maragakis N.J., Krishnan C., Rothstein J.D., Irani D.N., Kerr D.A. Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J. Neurosci. 2004, 24:7566-7575.
4. Diguet E., Fernagut P.O., Wei X., Du Y., Rouland R., Gross C., Bezard E., Tison F. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur. J. Neurosci. 2004, 19:3266-3276.
5. Dutta K., Basu A. Use of minocycline in viral infections. Indian J. Med. Res. 2011, 133:467-470.
6. Gordon P.H., Moore D.H., Miller R.G., Florence J.M., Verheijde J.L., Doorish C., Hilton J.F., Spitalny G.M., MacArthur R.B., Mitsumoto H., Neville H.E., Boylan K., Mozaffar T., Belsh J.M., Ravits J., Bedlack R.S., Graves M.C., McCluskey L.F., Barohn R.J., Tandan R. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007, 6:1045-1053.
7. Irani D.N., Prow N.A. Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis. J. Neuropathol. Exp. Neurol. 2007, 66:533-544.
8. Jackson A.C. Therapy of human rabies. Adv. Virus Res. 2011, 79:365-375.
9. Jackson A.C., Scott C.A., Owen J., Weli S.C., Rossiter J.P. Therapy with minocycline aggravates experimental rabies in mice. J. Virol. 2007, 81:6248-6253.
10. Martinez-Torres F., Menon S., Pritsch M., Victor N., Jenetzky E., Jensen K., Schielke E., Schmutzhard E., de G.J., Chung C.H., Luntz S., Hacke W., Meyding-Lamade U. Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC. Neurol. 2008, 8:40.
11. Metz L.M., Li D., Traboulsee A., Myles M.L., Duquette P., Godin J., Constantin M., Yong V.W. Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial. Mult. Scler. 2009, 15:1183-1194.
12. Mishra M.K., Basu A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J. Neurochem. 2008, 105:1582-1595.
13. Nikodemova M., Lee J., Fabry Z., Duncan I.D. Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord. J. Neuroimmunol. 2010, 219:33-37.
14. Plane J.M., Shen Y., Pleasure D.E., Deng W. Prospects for minocycline neuroprotection. Arch. Neurol. 2010, 67:1442-1448.
15. Ratai E.M., Bombardier J.P., Joo C.G., Annamalai L., Burdo T.H., Campbell J., Fell R., Hakimelahi R., He J., Autissier P., Lentz M.R., Halpern E.F., Masliah E., Williams K.C., Westmoreland S.V., Gonzalez R.G. Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS. PLoS One 2010, 5:e10523.
16. Richardson-Burns S.M., Tyler K.L. Minocycline delays disease onset and mortality in reovirus encephalitis. Exp. Neurol. 2005, 192:331-339.
17. Sacktor N., Miyahara S., Deng L., Evans S., Schifitto G., Cohen B.A., Paul R., Robertson K., Jarocki B., Scarsi K., Coombs R.W., Zink M.C., Nath A., Smith E., Ellis R.J., Singer E., Weihe J., McCarthy S., Hosey L., Clifford D.B. Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. Neurol. 2011, 77:1135-1142.
18. Seukeran D.C., Eady E.A., Cunliffe W.J. Benefit-risk assessment of acne therapies. Lancet 1997, 349:1251-1252.
19. Tsuji M., Wilson M.A., Lange M.S., Johnston M.V. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp. Neurol. 2004, 189:58-65.
20. Yang L., Sugama S., Chirichigno J.W., Gregorio J., Lorenzl S., Shin D.H., Browne S.E., Shimizu Y., Joh T.H., Beal M.F., Albers D.S. Minocycline enhances MPTP toxicity to dopaminergic neurons. J. Neurosci. Res. 2003, 74:278-285.
21. Yong V.W., Wells J., Giuliani F., Casha S., Power C., Metz L.M. The promise of minocycline in neurology. Lancet Neurol. 2004, 3:744-751.
22. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A 1998, 95:15769-15774.
23. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U. S. A 1999, 96:13496-13500.
24. Zhang Y., Metz L.M., Yong V.W., Bell R.B., Yeung M., Patry D.G., Mitchell J.R. Pilot study of minocycline in relapsing-remitting multiple sclerosis. Can. J. Neurol. Sci. 2008, 35:185-191.
25. Zink M.C., Uhrlaub J., DeWitt J., Voelker T., Bullock B., Mankowski J., Tarwater P., Clements J., Barber S. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005, 293:2003-2011.